Answers are grounded in this paper and cite their sources.
Oral diseases represent a significant global health burden. Given the limited therapeutic efficacy of conventional mechanical interventions and antimicrobial treatments, there is a critical demand for targeted, precision therapies. Gene editing has emerged as a revolutionary approach that modifies specific genes to alter cellular phenotypes, leading to significant advances in human medicine. This comprehensive narrative review evaluates the current state and developmental trends of gene editing, focusing on its transformative potential in oral disease management. This outlines the fundamental molecular mechanisms of the gene editing system and comprehensively synthesizes its cutting-edge therapeutic applications across diverse oral pathologies, including dental caries, oral squamous cell carcinoma (OSCC), and maxillofacial bone defects. Furthermore, to overcome the unique anatomical barriers of the oral cavity, advanced biomedical delivery strategies—including physical methods, viral vectors, nanoparticle carriers, hydrogels, and fiber membranes—are critically evaluated. However, current evidence remains predominantly preclinical, and major translational barriers, especially safe delivery and off-target effects, must be overcome before clinical application. In conclusion, gene editing technology, particularly the CRISPR-Cas9 system, enables the targeted modulation of gene expression, offers deeper insights into oral disease progression, and facilitates the development of innovative therapeutic strategies.
No takes yet. Share an insight, caveat, or question.
Wang et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: